IceCure Medical Gestion
Gestion contrôle des critères 4/4
IceCure Medical's CEO is Eyal Shamir, appointed in Sep 2016, has a tenure of 8.17 years. total yearly compensation is $553.00K, comprised of 75.3% salary and 24.7% bonuses, including company stock and options. directly owns 1.05% of the company’s shares, worth $422.24K. The average tenure of the management team and the board of directors is 5.9 years and 6 years respectively.
Informations clés
Eyal Shamir
Directeur général
US$553.0k
Rémunération totale
Pourcentage du salaire du PDG | 75.3% |
Durée du mandat du directeur général | 8.2yrs |
Propriété du PDG | 1.1% |
Durée moyenne d'occupation des postes de direction | 5.9yrs |
Durée moyenne du mandat des membres du conseil d'administration | 6yrs |
Mises à jour récentes de la gestion
Recent updates
Is IceCure Medical (NASDAQ:ICCM) In A Good Position To Invest In Growth?
Jul 31We're Keeping An Eye On IceCure Medical's (NASDAQ:ICCM) Cash Burn Rate
Nov 29Is IceCure Medical (NASDAQ:ICCM) In A Good Position To Deliver On Growth Plans?
Aug 08IceCure gains 19% on seeking FDA nod for cancer treatment
Oct 19IceCure files application for approval of ProSense in Canada for tumors
Jul 25IceCure Medical: Advancing Cryotherapy For Cancer Treatment
Jan 25Analyse de la rémunération des PDG
Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$14m |
Mar 31 2024 | n/a | n/a | -US$14m |
Dec 31 2023 | US$553k | US$416k | -US$15m |
Sep 30 2023 | n/a | n/a | -US$16m |
Jun 30 2023 | n/a | n/a | -US$16m |
Mar 31 2023 | n/a | n/a | -US$16m |
Dec 31 2022 | US$658k | US$467k | -US$17m |
Sep 30 2022 | n/a | n/a | -US$16m |
Jun 30 2022 | n/a | n/a | -US$15m |
Mar 31 2022 | n/a | n/a | -US$13m |
Dec 31 2021 | US$489k | US$426k | -US$10m |
Sep 30 2021 | n/a | n/a | -US$8m |
Jun 30 2021 | n/a | n/a | -US$6m |
Mar 31 2021 | n/a | n/a | -US$4m |
Dec 31 2020 | US$420k | US$370k | -US$4m |
Sep 30 2020 | n/a | n/a | -US$4m |
Jun 30 2020 | n/a | n/a | -US$4m |
Mar 31 2020 | n/a | n/a | -US$4m |
Dec 31 2019 | n/a | n/a | -US$5m |
Sep 30 2019 | n/a | n/a | -US$5m |
Jun 30 2019 | n/a | n/a | -US$4m |
Mar 31 2019 | n/a | n/a | -US$4m |
Dec 31 2018 | US$350k | US$251k | -US$4m |
Sep 30 2018 | n/a | n/a | -US$3m |
Jun 30 2018 | n/a | n/a | -US$3m |
Mar 31 2018 | n/a | n/a | -US$3m |
Dec 31 2017 | US$312k | US$259k | -US$3m |
Rémunération vs marché: Eyal's total compensation ($USD553.00K) is about average for companies of similar size in the US market ($USD655.65K).
Rémunération et revenus: Eyal's compensation has been consistent with company performance over the past year.
PDG
Eyal Shamir (63 yo)
8.2yrs
Titularisation
US$552,996
Compensation
Mr. Eyal Shamir serves as Chief Executive Officer and Director at IceCure Medical Ltd. since September 2016 and December 2017 respectively. Mr. Shamir served as Chief Executive Officer of Tadbik Pack Ltd.,...
Équipe de direction
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
CEO & Director | 8.2yrs | US$553.00k | 1.05% $ 422.2k | |
CFO & COO | 7.5yrs | US$405.26k | 0.62% $ 249.4k | |
Vice President of Business Development & Global Marketing | 5.9yrs | US$320.70k | 0.32% $ 126.9k | |
Vice President of Human Resources | 3yrs | US$282.17k | 0.12% $ 47.1k | |
Vice President of Operations & Service | 1.9yrs | pas de données | 0.11% $ 45.7k |
5.9yrs
Durée moyenne de l'emploi
55yo
Âge moyen
Gestion expérimentée: ICCM's management team is seasoned and experienced (5.9 years average tenure).
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
CEO & Director | 6.9yrs | US$553.00k | 1.05% $ 422.2k | |
Independent External Director | 5.2yrs | US$205.58k | pas de données | |
Independent External Director | 11.2yrs | pas de données | 0.020% $ 8.1k | |
Chairman of the Board | 6.9yrs | US$62.23k | 0.45% $ 180.5k | |
Independent Director | 1.9yrs | pas de données | pas de données | |
Director | 4.6yrs | pas de données | 0.15% $ 59.5k |
6.0yrs
Durée moyenne de l'emploi
61yo
Âge moyen
Conseil d'administration expérimenté: ICCM's board of directors are considered experienced (6 years average tenure).